New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: NewLead Holdings Ltd (NASDAQ:NEWL), Horizon Pharma Inc (NASDAQ:HZNP), Advanced Cell Technology, Inc (OTCMKTS:ACTC), McEwen Mining Inc (NYSE:MUX)
NewLead Holdings Ltd (NASDAQ:NEWL) showed a volume of 1.40 million shares by the end of last trade whereas the average volume of the stock remained 572,954.00 shares. The stock opened the session at $1.55 but then moved to $1.50. At that price, the stock showed a negative performance of -2.60%. NewLead Holdings Ltd. (NewLead) is an international shipping company engaged in the transportation of refined products, such as gasoline and jet fuel, and dry bulk goods, such as iron ore, coal and grain. NewLead operates in two segments: wet operations, which consists of tankers transporting several different refined petroleum products simultaneously in segregated, coated cargo tanks,
Will NEWL Get Buyers Even After The Recent Rally? Find Out Here
Horizon Pharma Inc (NASDAQ:HZNP) opened the session at $8.95 and closed the session at $8.59. The stock showed a negative performance of -2.28% in previous trading session. Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Has HZNP Found The Bottom And Ready To Gain Momentum? Find Out Here
Advanced Cell Technology, Inc (OTCMKTS:ACTC) opened the session at $0.06 and closed the session at $0.0584. The stock showed a negative performance of -0.50% in previous trading session. Traded with volume of 9.93 million shares in the prior session and the average volume of the stock remained 5.59 million shares. The beta of the stock remained -0.399. Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintained a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.
Why Should Investors Buy ACTC After the Recent Fall? Just Go Here and Find Out
McEwen Mining Inc (NYSE:MUX) the stock decreased -0.748% and finished the session at $2.07. Traded with volume of 1.39 million shares in the prior session and the average volume of the stock remained 2.14 million shares. The beta of the stock remained -0.28. McEwen Mining Inc. (McEwen Mining), formerly US Gold Corporation, is engaged in the exploration for and production of precious metals in the United States, Mexico and Argentina. McEwen Mining’s operating segments include USA and Mexico. The Company holds an interest in numerous exploration and development stage properties and projects in Nevada, Mexico and Argentina, as well as a 49% equity interest in the gold-silver San Jose Mine in Santa Cruz Province, Argentina.
Will MUX Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)